| Methods of increasing endogenous luteinizing hormone |
2022-9-30 |
2023-2-09 |
|
| Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids |
2022-7-15 |
2022-11-24 |
|
| Treatment of prostate cancer |
2022-7-15 |
2022-12-22 |
|
| Methods of treating subjects having diabetes with chronic kidney disease |
2022-1-26 |
2022-12-08 |
|
| Topical gel formulations and their use in treating skin conditions |
2021-6-24 |
2021-12-30 |
|
| An inhaled il-1 blockade treatment for respiratory tract immunopathology |
2021-5-20 |
2021-11-25 |
|
| Spirocyclic compounds as tryptophan hydroxylase inhibitors |
2021-3-15 |
2021-7-08 |
|
| Farber disease markers and uses thereof |
2021-3-08 |
2021-7-01 |
|
| Dosages and methods for treating pulmonary arterial hypertension with … |
2021-1-29 |
2021-8-05 |
|
| Treatment of lower airways disorders |
2020-12-02 |
2021-6-10 |
|
| Method of ameliorating a pro-inflammatory immunophenotype in farber disease … |
2020-1-17 |
2022-3-24 |
|
| A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) … |
2019-11-14 |
2020-5-22 |
|
| Micellic assemblies |
2019-9-23 |
2020-5-14 |
|
| Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2- … |
2019-8-21 |
2020-7-14 |
2020-7-14 |
| Nucleic acid constructs and methods of using the same |
2019-8-16 |
2020-5-26 |
2020-5-26 |
| Glucagon receptor antagonists |
2019-2-13 |
2021-4-29 |
|
| Methods for treating farber disease |
2019-1-31 |
2019-8-08 |
|
| Dosing regimens for the treatment of fungal infections |
2018-11-28 |
2019-6-06 |
|
| Use of vibegron to treat overactive bladder |
2018-6-06 |
2021-3-18 |
|
| Dosing of vibegron for treatment of overactive bladder |
2018-6-06 |
2021-3-18 |
|
| Branched peg molecules and related compositions and methods |
2017-12-29 |
2020-3-12 |
|
| Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
2017-11-30 |
2018-6-21 |
|
| Dosing regimens for the treatment of fungal infections |
2017-11-28 |
2019-5-28 |
|
| The fractionation of optical activity diaza spiro [4.5] decane derivative |
2017-11-09 |
2019-8-27 |
|
| Methods of using tryptophan hydroxylase inhibitors |
2017-9-29 |
2018-6-01 |
|
| Omega-functionalized polymers, junction-functionalized block copolymers, … |
2017-2-08 |
2017-5-25 |
|
| Multiblock copolymers |
2016-9-01 |
2017-2-23 |
|
| Methods, compositions, and systems for delivering therapeutic and diagnostic … |
2016-1-21 |
2018-8-09 |
|
| Bispecific intracellular delivery vehicles |
2015-12-02 |
2016-3-24 |
|
| Polymeric carrier |
2015-2-24 |
2015-8-27 |
|
| Targeting monomers and polymers having targeting blocks |
2010-11-17 |
2013-1-10 |
|
| Micelles for intracellular delivery of therapeutic agents |
2009-5-13 |
2011-6-16 |
|
| Heterogeneous polymeric micelles for intracellular delivery |
2009-5-13 |
2012-1-26 |
|
| Micelles of hydrophilically shielded membrane-destabilizing copolymers |
2009-5-13 |
2011-11-17 |
|
| Targeted polymer bioconjugates |
2009-5-13 |
2011-6-02 |
|